Edition:
United Kingdom

Insulet Corp (PODD.OQ)

PODD.OQ on NASDAQ Stock Exchange Global Select Market

105.34USD
25 Sep 2018
Change (% chg)

$2.74 (+2.67%)
Prev Close
$102.60
Open
$103.29
Day's High
$105.56
Day's Low
$102.60
Volume
162,422
Avg. Vol
222,122
52-wk High
$108.90
52-wk Low
$54.60

Chart for

About

Insulet Corporation is engaged in the development, manufacturing and sale of the OmniPod Insulin Management System (the OmniPod System), an insulin delivery system for people with insulin-dependent diabetes. The Omnipod System features a self-adhesive disposable tubeless Omnipod device, which is worn on the body for approximatel... (more)

Overall

Beta: 1.51
Market Cap(Mil.): $3,415.65
Shares Outstanding(Mil.): 58.06
Dividend: --
Yield (%): --

Financials

  PODD.OQ Industry Sector
P/E (TTM): -- 32.30 32.76
EPS (TTM): -0.52 -- --
ROI: -9.66 13.94 14.61
ROE: -64.91 16.79 16.33

BRIEF-Insulet Reports Q1 Loss Per Share $0.11

* INSULET REPORTS FIRST QUARTER 2018 REVENUE OF $123.6 MILLION, UP 21% YEAR-OVER-YEAR, AND GROSS MARGIN OF 61.4%, UP 300 BASIS POINTS, EXCEEDING EXPECTATIONS

03 May 2018

BRIEF-Insulet Establishes Two Significant Commercial Partnerships To Support Its European Expansion

* INSULET ESTABLISHES TWO SIGNIFICANT COMMERCIAL PARTNERSHIPS TO SUPPORT ITS EUROPEAN EXPANSION

01 May 2018

BRIEF-Insulet Corp Says CEO's 2017 Total Compensation Was $8.2 Mln Vs $6 Mln In 2016

* INSULET CORP SAYS CEO PATRICK J. SULLIVAN'S 2017 TOTAL COMPENSATION WAS $8.2 MLN VS $6 MLN IN 2016 – SEC FILING‍​‍​ Source text: (https://bit.ly/2EsXkmY) Further company coverage:

06 Apr 2018

Competitors

Earnings vs. Estimates